Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to establish the bioequivalence of survodutide in a pre-filled syringe (reference product \[formulation A\]) and in a vial (test product \[formulation B2\]) in male and female trial participants who are healthy or otherwise healthy with overweight/obesity, following subcutaneous administration.
Official title: Bioequivalence of Survodutide (BI 456906) When Administered Via Pre-filled Syringe (Formulation A) and Vial (Formulation B2) in Male and Female Trial Participants Who Are Healthy or Otherwise Healthy But Overweight/Obese (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2026-09-01
Completion Date
2026-12-22
Last Updated
2026-08-18
Healthy Volunteers
Yes
Interventions
Survodutide formulation A
Pre-filled pen
Survodutide formulation B2
Survodutide formulation B2
Locations (1)
hVIVO Mannheim
Mannheim, Germany